A remarkable surge in Mecure Industries’ shares has catapulted the combined stake of Indian father-son duo, Samir and Arjun Udani, to approximately $186.49 million.
The Nigerian pharmaceutical manufacturer’s stock price has jumped from 30.70 naira on November 3, 2025, to 104 naira, representing a staggering 238.76% gain in under three months.
As the chairman and founder, Samir Udani holds 1,291,779,280 shares worth around $93.95 million, while his son, Arjun Udani, co-CEO responsible for finance and supply chain, holds 1,272,459,257 shares valued at approximately $92.54 million. The Udanis’ combined stake is now worth around 266.68 billion naira.
Mecure Industries, established in 2005, produces medicines and consumer health products, including nutraceuticals, and has a market capitalization of 416 billion naira ($290 million).
The company’s listing on the Nigerian Exchange in November 2023 has been a resounding success, with its stock price rising over 34 times from the initial listing level.
The surge in Mecure’s shares has sparked debate in Lagos dealing rooms about the factors driving the price move, with some attributing it to the company’s tightly held structure and limited shares available for trading.
